About The Report
The coronary artery bypass graft market in the United Kingdom is projected to grow from USD 2.3 billion in 2026 to USD 3.1 billion by 2036, at a CAGR of 3.1%. While the market shows steady growth, it is subject to significant execution risk. Hospitals and healthcare systems are increasingly faced with pressure to optimize surgical outcomes while controlling costs, which may affect adoption rates for new techniques or technologies. Friction in adoption may arise from the complexity of procedures and the need for specialized training, limiting faster uptake in some institutions. Additionally, the market is highly sensitive to economic fluctuations; any downturn in healthcare funding or changes in insurance reimbursement policies could dampen growth. On the other hand, a stable healthcare system and increased awareness of heart disease could provide steady demand. For suppliers, managing these risks requires balancing innovation with cost efficiency and ensuring that both technological and operational hurdles are addressed effectively.
Demand for coronary artery bypass graft (CABG) procedures in the United Kingdom is expected to increase steadily through the forecast period. Growth is supported by an aging population and the continued burden of cardiovascular disease, which keeps surgical revascularization relevant for complex and high-risk cases. Hospitals are also improving cardiac care pathways, which supports consistent procedure volumes over time.
Growth rate volatility is likely to remain moderate, as the segment can be influenced by shifts toward alternative treatments such as percutaneous coronary interventions, changes in clinical guidelines, and NHS funding priorities. Even with these fluctuations, CABG is expected to maintain stable long-term demand due to its established clinical role in severe coronary artery disease management.
| Metric | Value |
|---|---|
| Industry Sales Value (2026) | USD 2.3 billion |
| Industry Forecast Value (2036) | USD 3.1 billion |
| Industry Forecast CAGR (2026 to 2036) | 3.1% |
Demand for coronary artery bypass graft procedures in the United Kingdom has shifted over time as clinical needs and treatment pathways evolved. Data spanning multiple years show that total procedural volumes for coronary artery bypass graft surgery recorded within NHS systems decreased in proportion relative to other cardiac interventions, yet absolute numbers remain significant with around 20,000 CABG procedures performed annually in England alone. This sustained procedure rate reflects an ongoing clinical role for surgical revascularisation in patients with advanced multi vessel coronary artery disease and complex lesions where percutaneous approaches may not achieve durable outcomes. Surgical teams and healthcare providers have maintained CABG as a critical option for patients with left main coronary stenosis, diabetes with coronary disease, or extensive atherosclerotic burden, where evidence and guidelines continue to recommend surgical intervention. Over extended periods, outcome metrics such as in hospital mortality have improved, which supports clinician confidence in referring appropriate patients for surgical revascularisation.
Looking ahead, demand for coronary artery bypass graft in the United Kingdom is expected to evolve rather than simply rise, influenced by demographic, clinical, and service delivery factors. An ageing population with a high burden of coronary risk factors will sustain baseline need for revascularisation services that include CABG alongside evolving percutaneous interventions. UK healthcare providers and cardiac surgery programmes will need to balance resource planning between minimally invasive coronary treatments and surgical options, particularly for high risk cohorts where long term outcomes favour bypass grafting. Hospitals and suppliers serving this market will value technologies and consumables that support both conventional and hybrid surgical approaches, including off pump techniques and advanced graft preservation tools. Buyers will prioritise systems that enhance procedural efficiency, perioperative safety, and integration with digital surgical planning platforms, given healthcare pressures and expectations for quality outcomes. Continued emphasis on evidence based patient selection, procedure optimisation, and service capacity planning will shape how demand for CABG procedures is addressed by clinical teams and supply partners in the UK.
Demand for coronary artery bypass graft (CABG) in the United Kingdom is primarily driven by technology and end-user sectors. On-pump CABG leads the technology segment with 80%, while hospitals dominate the end-user segment with 60%. Other technologies, such as off-pump CABG, and end-users like cardiology clinics and research institutes, also contribute to the market. These trends reflect the ongoing need for effective cardiac surgery solutions and the growing emphasis on improving patient outcomes in both clinical and research environments.
The technology segment for coronary artery bypass graft (CABG) in the United Kingdom is led by on-pump CABG, which accounts for 80% of the market share. On-pump CABG is the traditional approach to bypass surgery, where the patient’s heart is temporarily stopped, and a heart-lung machine is used to pump blood and oxygen throughout the body while the surgeon works on the coronary arteries. This method is widely favored due to its established success rate and predictable outcomes, particularly in complex surgeries involving multiple blocked arteries.
On-pump CABG is commonly used in cases where precise control over the heart’s function is necessary, and it remains the preferred choice for most coronary artery bypass surgeries. Off-pump CABG, although a smaller segment, offers the advantage of performing the surgery while the heart continues to beat, avoiding the use of a heart-lung machine. This approach is particularly beneficial in certain patient populations, such as those with significant co-morbidities or those at higher risk for complications associated with the use of a heart-lung machine.
The off-pump procedure can lead to faster recovery times and lower complication rates in certain cases. While it is not as widely used as on-pump CABG, the adoption of off-pump CABG continues to grow as surgical techniques evolve and technology improves. Other technologies in the CABG field, although representing a smaller portion of the market, include minimally invasive approaches and robotic-assisted surgery, which aim to reduce recovery time and improve surgical precision.
The end-user segment for coronary artery bypass graft (CABG) in the United Kingdom is dominated by hospitals, which account for 60% of the market share. Hospitals are the primary setting for CABG surgeries due to their ability to provide the necessary infrastructure, including intensive care units (ICUs), skilled surgical teams, and advanced medical equipment. CABG surgeries are typically performed in hospitals with specialized cardiac surgery departments, where patients can receive comprehensive care before, during, and after surgery.
The demand for CABG in hospitals is driven by the high prevalence of coronary artery disease (CAD) and the need for life-saving surgical interventions for patients with severe blockages in their coronary arteries. Hospitals provide the resources and specialized care required for complex surgeries, including on-pump and off-pump procedures, making them the largest segment for CABG surgeries. Cardiology clinics follow as another significant end-user, although their role in CABG surgeries is more focused on pre-operative assessment, diagnosis, and post-operative care. These clinics play an important role in managing patients with heart disease and helping them determine whether CABG surgery is necessary.
Research institutes also contribute to the CABG market, particularly through clinical trials and studies aimed at improving surgical techniques, patient outcomes, and recovery times. While research institutes represent a smaller share of the market, they are essential for advancing the field of cardiac surgery and exploring new technologies. Other end-users include outpatient surgery centers and specialized cardiac care centers, which are becoming increasingly involved in offering minimally invasive or robotic-assisted CABG procedures. As the demand for coronary artery bypass surgeries continues to grow, hospitals remain the key driver of the market, but the involvement of other sectors, such as cardiology clinics and research institutions, is expected to increase as the field evolves.
Demand for coronary artery bypass graft (CABG) procedures in the United Kingdom is shaped by the prevalence of coronary artery disease (CAD), capacity within cardiac surgical units, referral patterns from cardiology services, and national clinical guidelines. CABG remains a central treatment for multi vessel disease and complex coronary blockages, complementing percutaneous coronary interventions (PCI) where clinically appropriate. Procurement of surgical equipment, graft materials, and support devices aligns with hospital cardiac surgery volumes, waiting list management policies, and investment in cardiovascular units. Demand also reflects regional variations in healthcare service provision and referral pathways within NHS trusts and private cardiac care providers.
Several factors drive demand for CABG procedures in the United Kingdom. High prevalence of CAD, tied to risk factors such as aging population, hypertension, diabetes, and lifestyle influences, sustains a baseline need for revascularisation therapy. National Institute for Health and Care Excellence (NICE) guidance that delineates indications for surgical intervention ensures consistent clinical decision making across acute trusts and specialist centres. Improvements in diagnostic imaging and risk stratification facilitate earlier identification of candidates for CABG, supporting procedural planning. Capacity expansion in tertiary cardiac centres, investment in hybrid operating theatres, and dedicated intensive care resources also enable higher procedural throughput.
Despite its clinical role, demand for CABG in the United Kingdom is moderated by several restraints. Ongoing expansion and preference for minimally invasive alternatives such as PCI with drug eluting stents can reduce surgical referral volumes for selected patient subsets. Hospital resource constraints, including theatre availability, cardiac ICU capacity, and specialist surgical staffing, limit throughput and contribute to waiting times. Variability in regional healthcare funding and capital planning impacts the ability of some trusts to prioritise investment in cardiac surgical infrastructure. Patient co morbidities and frailty in older populations can also influence eligibility, shifting some care pathways toward conservative or hybrid interventions.
Key trends influencing CABG demand in the United Kingdom include integration of hybrid revascularisation strategies that combine surgical and catheter based techniques to optimise outcomes for complex coronary disease. Investment in enhanced recovery after surgery (ERAS) protocols and perioperative care pathways aims to reduce length of stay and improve resource utilisation in cardiac units. Use of advanced graft materials, including arterial conduits and composite grafting techniques, reflects clinical emphasis on long term patency and patient outcomes. Data driven performance monitoring across cardiac networks supports benchmarking and optimisation of referral and treatment pathways. Collaborative care models between cardiologists and cardiac surgeons enhance patient selection and align treatment strategy with individual risk profiles.
The demand for Coronary Artery Bypass Graft (CABG) surgery in the United Kingdom shows regional disparities, with England leading the market. The demand in England is driven by its larger population, higher incidence of cardiovascular diseases, and advanced healthcare infrastructure. CABG is widely performed to treat severe coronary artery disease, and as the number of people with heart-related conditions continues to rise, so does the demand for surgical interventions. Scotland, Wales, and Northern Ireland also show significant demand, driven by aging populations, increasing rates of lifestyle diseases, and the need for advanced cardiovascular care. While England remains the largest market for CABG, steady growth in demand is anticipated across all regions as healthcare systems continue to prioritize heart disease treatments and improve access to surgical options.
| Country | CAGR (2026 to 2036) |
|---|---|
| England | 3.4% |
| Scotland | 3.0% |
| Wales | 2.8% |
| Northern Ireland | 2.4% |
The demand for Coronary Artery Bypass Graft (CABG) surgery in England is projected to grow at a CAGR of 3.4% from 2026 to 2036. The primary factors contributing to this demand include an aging population, a high incidence of cardiovascular diseases, and advancements in surgical techniques. England’s well-established healthcare infrastructure, including its large network of hospitals and cardiovascular specialists, plays a critical role in the rising demand for CABG. The increasing prevalence of risk factors such as diabetes, hypertension, and obesity also contributes to the growing need for coronary artery surgeries. With improved survival rates following surgery, more patients are seeking CABG as an effective treatment for severe coronary artery disease. The focus on early diagnosis, better access to healthcare services, and advancements in minimally invasive CABG procedures will likely continue to support growth in the demand for these surgeries.
In Scotland, the demand for CABG surgery is expected to grow at a CAGR of 3.0% from 2026 to 2036. Scotland’s healthcare system, which is focused on providing specialized treatments for cardiovascular diseases, is a key driver for this demand. The rise in lifestyle-related diseases, such as smoking, high-fat diets, and sedentary lifestyles, has led to an increase in coronary artery disease in Scotland, fueling the need for CABG procedures. Additionally, the aging population in Scotland, coupled with improved diagnostic capabilities and better access to healthcare services, is driving more patients to opt for CABG. Scotland’s continued efforts to reduce heart disease mortality, as well as the growing adoption of advanced surgical techniques, will contribute to the growth in demand for CABG surgery in the region over the next decade.
The demand for CABG surgery in Wales is projected to grow at a CAGR of 2.8% through 2036. Similar to other regions, the key factors driving this growth are the aging population and the rising incidence of heart disease. Lifestyle factors such as poor diet, high stress, and lack of exercise contribute to the growing number of people suffering from coronary artery disease in Wales. As the healthcare system continues to improve access to specialized treatments and surgical interventions, CABG will remain a critical part of the cardiovascular treatment landscape. Moreover, the adoption of newer, less invasive surgical techniques and a stronger emphasis on preventive healthcare are helping to drive the demand for CABG in Wales. As the region continues to invest in heart disease prevention and treatment, the demand for coronary artery bypass surgeries is expected to grow steadily.
Northern Ireland’s demand for CABG surgery is expected to grow at a CAGR of 2.4% from 2026 to 2036. While Northern Ireland represents the smallest market for CABG in the UK, the demand is still increasing, driven by the aging population and rising cardiovascular disease rates. The demand for CABG is being influenced by factors such as an increase in diabetes, obesity, and hypertension in the population, as well as the growing need for effective coronary artery disease treatments. Northern Ireland’s healthcare infrastructure, including cardiovascular centers of excellence, is improving, providing better access to these surgical procedures. The growing emphasis on heart disease prevention, along with advances in surgical techniques, will ensure a steady increase in CABG demand in Northern Ireland, despite the smaller market size.
Demand for coronary artery bypass graft (CABG) solutions in the United Kingdom is shaped by procedural volumes in National Health Service facilities and private cardiac centres, clinical protocol updates, and investment in surgical infrastructure. Hospitals and surgical departments specify graft systems based on documented patency rates, handling characteristics, and compatibility with off pump and on pump techniques. Medtronic plc is positioned as a leading supplier, with product brochures that list documented clinical outcomes, documented graft material options (arterial and venous), and documented sizing matrices used by surgical teams during specification alignment. These technical documents are reviewed by purchasing and clinical governance teams to match surgical quality targets with evidence based performance data. Procurement decisions also factor in documented sterilization standards, documented shelf life, and documented training support for theatre staff.
Terumo Corp. competes with CABG systems accompanied by detailed documentation on graft flexibility, documented compliance with UK regulatory requirements, and documented clinical use cases. Buyers evaluate these materials to ensure that selected products integrate with existing surgical workflows and quality assurance processes. Guidant Group supplies graft and associated delivery systems documented for ease of deployment and documented haemocompatibility metrics, which are assessed by cardiothoracic surgery departments during tender reviews. Getinge AB offers documented perfusion and support technologies that complement graft procedures, with technical literature outlining documented pump system performance, documented safety protocols, and documented service response frameworks.
In the United Kingdom, procurement cycles incorporate documented performance data, documented product support terms, and documented distribution lead times. Hospitals compare documented clinical evidence and documented cost profiles to align supply agreements with procedural budgets and quality targets. Clinical users and procurement teams jointly review documented handling profiles and documented compatibility notes to ensure that graft solutions meet both surgical preferences and institutional quality standards. Competitive activity is anchored in measurable technical specifications and documented support commitments that assist procurement professionals in securing reliable CABG systems for cardiac programmes.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD Billion |
| Technology | Off-pump CABG, On-pump CABG, Others |
| Procedure | Single CABG surgery, Double CABG surgery, Triple CABG surgery, Quadruple CABG surgery, Others |
| End User | Hospitals, Cardiology Clinics, Research Institutes, Others |
| Companies | Medtronic plc, Terumo Corp., Guidant Group, Getinge AB |
| Regions Covered | United Kingdom |
| Countries Covered | England, Scotland, Wales, Northern Ireland |
| Additional Attributes | Dollar by sales by technology, procedure, end user, and region. Includes market trends towards minimally invasive techniques, cost-effectiveness, and the role of CABG in heart disease treatment. |
The demand for coronary artery bypass graft in United Kingdom is estimated to be valued at USD 2.3 billion in 2026.
The market size for the coronary artery bypass graft in United Kingdom is projected to reach USD 3.1 billion by 2036.
The demand for coronary artery bypass graft in United Kingdom is expected to grow at a 3.1% CAGR between 2026 and 2036.
The key product types in coronary artery bypass graft in United Kingdom are on-pump cabg, off-pump cabg and others.
In terms of technology, On-pump CABG surgery segment is expected to command 80.0% share in the coronary artery bypass graft in United Kingdom in 2026.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Coronary Artery Bypass Grafts Market Size and Share Forecast Outlook 2025 to 2035
Demand for Coronary Artery Bypass Graft in South Korea Size and Share Forecast Outlook 2026 to 2036
Demand for Coronary Artery Bypass Graft in Japan Size and Share Forecast Outlook 2025 to 2035
Demand for Coronary Artery Bypass Graft in USA Size and Share Forecast Outlook 2025 to 2035
Demand for Respiratory Inhaler Devices in UK Size and Share Forecast Outlook 2026 to 2036
United Kingdom Interesterified Fats Market Size and Share Forecast Outlook 2025 to 2035
United Kingdom Car Rental Market Analysis – Growth, Applications & Outlook 2025–2035
United Kingdom (UK) Veneered Panels Market Analysis & Insights for 2025 to 2035
United Kingdom Women's Footwear Market Trends-Growth & Industry Outlook 2025 to 2035
United Kingdom Automotive Turbocharger Market Outlook – Share, Growth & Forecast 2025–2035
United Kingdom Yeast Market Analysis – Size, Share & Forecast 2025–2035
United Kingdom Green and Bio-based Polyol Market Analysis – Size, Share & Forecast 2025–2035
United Kingdom Natural Food Color Market Outlook – Share, Growth & Forecast 2025–2035
United Kingdom Coated Fabrics Market Insights – Demand, Size & Industry Trends 2025–2035
United Kingdom Barite Market Analysis – Size, Share & Forecast 2025–2035
United Kingdom Compact Construction Equipment Market Growth – Trends, Demand & Innovations 2025–2035
UK Curtain Walling Market Report - Growth, Demand & Forecast 2025 to 2035
United Kingdom Flare Gas Recovery System Market Analysis – Size, Share & Forecast 2025–2035
United Kingdom Electric Golf Cart Market Growth – Demand, Trends & Forecast 2025–2035
United Kingdom Magnetic Separator Market Analysis – Size, Share & Forecast 2025-2035
Demand for Coronary Artery Bypass Graft in United Kingdom
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
